Heart patch could catch drug risks better than standard ECG

NCT ID NCT04336644

First seen Jan 09, 2026 · Last updated Jun 12, 2026 · Updated 24 times

Summary

This study tests whether a continuous heart monitor patch can better detect dangerous heart rhythms in people taking specific cancer drugs (arsenic trioxide, capecitabine, or ribociclib) compared to standard, intermittent ECGs. About 60 adults will wear the patch for several days while their heart activity is tracked. The goal is to see if the patch provides more accurate and timely warnings of heart complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG QT SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.